Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
α-グルコシダーゼ阻害剤及び血糖値上昇抑制剤
Document Type and Number:
Japanese Patent JP7249006
Kind Code:
B2
Abstract:
To provide a new composition having a superior blood glucose level elevation inhibitory capacity.SOLUTION: An α-glucosidase inhibitor and a blood glucose level elevation inhibitor of this invention include as active principle a Terminalia bellirica extract containing gallic acid or salt thereof.SELECTED DRAWING: None

Inventors:
Satohana Nagamine
Kinya Takagaki
Application Number:
JP2018203201A
Publication Date:
March 30, 2023
Filing Date:
October 29, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Toyo Shinyaku Co., Ltd.
International Classes:
A23L33/105; A61K31/192; A61K36/185; A61P3/10; A61P43/00
Domestic Patent References:
JP2017105728A
JP2020018294A
JP2006188494A
JP2017112935A
Other References:
MAKIHARA Hiroko et al.,Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice,J. Nat. Med.,2012年,vol. 66,p. 459-467
MAKIHARA Hiroko et al.,Gallic Acid, the Active Ingredient of Terminalia bellirica, Enhances Adipocyte Differentiation and Adiponectin Secretion,Biol. Pharm. Bull.,2016年,vol. 39,p. 1137-1143
OBOH Ganiyu et al.,Influence of gallic acid on a-amylase and a-glucosidase inhibitory properties of acarbose,journal of food and drug analysis,2016年,vol. 24,p. 627-634



 
Previous Patent: Massage machine

Next Patent: curing sheet